Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (9989) Revenue

2 Followers

Statistics Market Cap Revenue

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Revenue

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H had a revenue of 1.33B in the quarter ending Mar 31, 2026, with 3.61%. This bring the company's revenue in the last twelve months to 5.42B, Increased -1.16%. In the fiscal year ending Dec 31, 2025, Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H had annual revenue of 5.48B with 3.75% growth.

Revenue (ttm)

5.42B

Revenue Growth

3.74%

P/S Ratio

3.03

Revenue/Employee

HK$2,844,747

Employees

1,926

Market Cap

HK$16.61B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	5.48B	198.27M	+3.75%
Dec 31, 2024	5.28B	-164.86M	-3.03%
Dec 31, 2023	5.45B	-1.71B	-23.94%
Dec 31, 2022	7.16B	794.23M	+12.48%
Mar 31, 2022	6.37B	1.03B	+19.38%
Dec 31, 2020	5.33B	707.42M	+15.30%
Dec 31, 2019	4.62B	-190.31M	-3.95%
Dec 31, 2018	4.81B	2.14B	+80.32%
Dec 31, 2017	2.67B	―	―